Two polymorphisms of presenilin-2 gene (PSEN2) 5' regulatory region are not associated with Alzheimer's disease (AD) in the Polish population
- PMID: 18087668
- DOI: 10.1007/s00702-007-0846-x
Two polymorphisms of presenilin-2 gene (PSEN2) 5' regulatory region are not associated with Alzheimer's disease (AD) in the Polish population
Abstract
Presenilin 2 gene (PSEN2) is one of the causative genes for familial Alzheimer's disease. A delA polymorphism located in PSEN2 promoter was proposed to be a risk factor for early-onset AD. We examined association between AD and PSEN2 polymorphisms located in two 5'UTR regions in group of 217 late-onset AD patients, 109 mild cognitive impairment patients, and 225 non-demented control subjects. No significant differences for genotype and allele distributions of a delA and a novel insAC polymorphisms in the studied groups as compared to controls were observed. Univariate and multivariate risk estimation shows that neither delA, insAC alleles nor the genotypes are risk factors for AD. No significant interaction between the APOE4 and PSEN2 polymorphisms was found. A bioinformatic analysis showed that delA polymorphism influences binding sites of transcription factors involved in the cellular processes related to AD. The rare variants identified in exon 3 of the PSEN2 could have a potential influence on PSEN2 transcript splicing.
Similar articles
-
The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population.J Neurol Sci. 2008 Jan 15;264(1-2):38-42. doi: 10.1016/j.jns.2007.06.054. Epub 2007 Aug 28. J Neurol Sci. 2008. PMID: 17727891
-
Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD.Mol Psychiatry. 2002;7(8):891-8. doi: 10.1038/sj.mp.4001101. Mol Psychiatry. 2002. PMID: 12232783
-
Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.Ann Clin Transl Neurol. 2019 Mar 10;6(4):762-777. doi: 10.1002/acn3.755. eCollection 2019 Apr. Ann Clin Transl Neurol. 2019. PMID: 31020001 Free PMC article.
-
A brief history of Alzheimer's disease gene discovery.J Alzheimers Dis. 2013;33 Suppl 1:S5-13. doi: 10.3233/JAD-2012-129044. J Alzheimers Dis. 2013. PMID: 22986781 Review.
-
A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.J Alzheimers Dis. 2018;66(4):1323-1339. doi: 10.3233/JAD-180656. J Alzheimers Dis. 2018. PMID: 30412492 Review.
Cited by
-
Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.Dement Geriatr Cogn Dis Extra. 2016 Mar 16;6(1):90-7. doi: 10.1159/000444080. eCollection 2016 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2016. PMID: 27065294 Free PMC article.
-
Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients.Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):180-9. doi: 10.1159/000329514. Epub 2011 Jun 29. Dement Geriatr Cogn Dis Extra. 2011. PMID: 22163243 Free PMC article.
-
Current status on Alzheimer disease molecular genetics: from past, to present, to future.Hum Mol Genet. 2010 Apr 15;19(R1):R4-R11. doi: 10.1093/hmg/ddq142. Epub 2010 Apr 13. Hum Mol Genet. 2010. PMID: 20388643 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
